Rusten group research project on cell organisation and tumor growth highlighted by the Norwegian Cancer Society

The Norwegian Cancer Society awarded NOK 173.8 millions NOK to cancer research through the annual open announcement in 2017. They publish popular science articles about research projects supported by them regularly.

The research of Tor Erik Rusten and his coworkers in from the Tumor-Host Biology research group at the Department of Molecular Cell Biology at the Institute for Cancer Research has recently been presented in an article (in Norwegian) entitled "Double agent in the body's cells makes tumors grow". Here it is explained how tumor cells lose orientation and grow uncontrollably when the "double agent" protein LKB1 leads the cells in the wrong direction under certain conditions.

 

Photo from the Norwegian Cancer Society article (photo: Per Marius Didriksen)

 

Links:

The article, from the home page of the Norwegian Cancer Society:
Dobbeltagent i kroppens celler får svulster til å vokse , written by Håkon Sandland (published Jan 9th 2018)

Norwegian Cancer Society and research support


Previous news articles about the Rusten group from ous-research.no:

Rusten group uncovers new regulatory mechanism of the Peutz-Jeghers cancer syndrome kinase, LKB1

Findings from Rusten group published in Nature on microenvironmental autophagy draw nationwide attention


Home page of Tor Erik Rusten´s group Tumor - Host Biology

Department of Molecular Cell Biology


Centre for Cancer Cell Reprogramming (CanCell)

 
Page visits: 850